Can I Mix CBD With Nicotine?
Definition
Nicotine and cannabidiol turn up in the same question all the time, usually because someone takes both in the same day. This page keeps them apart: what the cited pharmacokinetic work has measured about CBD, and where the record on the combination stops. No study on the pairing is named here, because there isn't one to name.
So what is actually being asked?
Two substances, one day, one question. It splits in two the moment you look at it.
The first half can be answered in part. Cannabidiol has a documented route through the body: it travels largely via the liver, where a family of breakdown agents known as the cytochrome P450 enzymes does the work [1]. That part is mapped. The second half is where the record thins. In the human pharmacokinetic literature reviewed by Millar and colleagues in 2018, blood concentrations of cannabidiol are reported against route of administration and dose, and the authors describe the available human data as limited and heterogeneous [2]. Nicotine sitting alongside cannabidiol is not part of that picture.
So the answer here is a boundary rather than a verdict. We can tell you what has been measured about CBD. We cannot hand you a study on the two together, because we cannot cite one.
- Documented: the individual enzymes that metabolise cannabidiol, identified under laboratory conditions by Jiang and colleagues in 2011 [1].
- Documented: blood concentrations in people, sorted by how the cannabidiol was taken and how much of it [2].
- Not documented in either paper: a controlled look at cannabidiol and nicotine in the same protocol.
- Variable: exposure differed widely across the reviewed studies and across individual participants [2].
- Practical: anything you take regularly, in any format, belongs in a conversation with your doctor or pharmacist.
One organ, a family of enzymes
Cannabidiol's path runs largely via the liver. There, a group of proteins called the cytochrome P450 enzymes acts as the breakdown agent [1]. P450 is not a single enzyme. It is a large family, and its members handle different molecules at different rates.
Jiang and colleagues tested that directly in 2011. They incubated cannabidiol with human liver microsomes, the prepared fragments of liver tissue used for this kind of laboratory work. The output was an identification: the individual cytochrome P450 enzymes responsible for metabolising cannabidiol [1]. Names on a list. Not a figure for how much of anything happens inside a living person.
Millar and colleagues came at it from the human side in 2018, reviewing the published pharmacokinetic work and setting blood concentrations against route of administration and dose [2]. Their own description of that evidence base is the part worth keeping: limited, and heterogeneous [2]. Much of the published work stays preliminary, with small participant numbers, study designs that differ from each other, and outcomes not yet reproduced at a scale you could generalise from.
If you want the enzyme families gone through one at a time, our guide to liver enzyme metabolism does that at length.
- The 2011 result comes from liver tissue in a laboratory, not from measurements taken in people [1].
- Route of intake is named as the driver of cannabidiol exposure, which is why an oil, a capsule and an inhaled format do not share one number [2].
- Formulation, route and product quality all shape cannabidiol's own profile, which is why a batch report tells you more than a category name [2].
What each paper measured
| Source | Material used | What it reports | What it leaves open |
|---|---|---|---|
| Jiang and colleagues, 2011 [1] | Cannabidiol incubated with human liver microsomes under laboratory conditions | An identification of the individual cytochrome P450 enzymes responsible for the metabolism of cannabidiol | The size of that activity in a living person, and what shifts when a second substance is present |
| Millar and colleagues, 2018 [2] | A systematic review of the human pharmacokinetic literature on cannabidiol | Blood concentrations set against route of administration and dose, with route named as the driver of exposure | Consistent figures. The authors call the human data limited and heterogeneous, and variance ran high across studies and participants |
| The pairing itself | Neither cited paper put cannabidiol and nicotine into the same protocol | Nothing. The row stays blank, and filling it with a guess would be worse than leaving it empty | Order, amounts, formats, timing, individual differences: all of it |
| Our editorial rule since 2014 | Working with cannabinoids since the category still needed explaining | A claim gets published with a paper behind it, named by author and year, or it does not get published | This page is not a substitute for a pharmacist who can see your full list of products and medicines |
What moves the numbers
| Variable | What the reviewed literature attaches to it | How firm the evidence is |
|---|---|---|
| Route of intake | Named as the driver of cannabidiol exposure across the reviewed human studies [2] | Reported, though the underlying human data are described as limited and heterogeneous [2] |
| Dose | Blood concentrations are reported against dose as well as route [2] | Reported per study, not as one transferable figure |
| Formulation | Cannabidiol has its own profile, shaped by formulation alongside route and quality [2] | Drawn from the human pharmacokinetic literature, with high variance between studies |
| Product quality | Listed among the factors shaping how cannabidiol behaves [2] | Checkable on your side through a batch analysis, not through a study |
| The individual | Variance was high between participants, not only between study designs [2] | Consistently observed, and one reason single results travel badly |
| Metabolic route | Cannabidiol is broken down largely in the liver by cytochrome P450 enzymes [1] | Identified by name in laboratory work on human liver tissue, without a human magnitude attached [1] |
| Nicotine alongside it | Absent from both cited papers | No evidence either way, which is not the same thing as reassurance |
Notes to take before you ask
| Note | Why it belongs on the page | Where to find it |
|---|---|---|
| Every product you take | A pharmacist can only work with the complete list, medicines and supplements together | Your own shelf, plus repeat prescription slips |
| Format and route | Route of administration is the factor tied most directly to cannabidiol exposure in the reviewed work [2] | The front of the pack: oil, capsule, or something inhaled |
| Milligrams per serving | Blood concentrations in the human literature are reported against dose, so the number matters more than the strength label [2] | The label, then the batch report to confirm it |
| The batch analysis | Quality is one of the factors shaping cannabidiol's profile, and an independent analysis is how you verify it [2] | The batch number on the bottle, matched to the published report |
| How often, and since when | Frequency and history give a professional context that a single reading cannot | A note on your phone is enough |
| The question in one line | Specific questions get specific answers, and the enzyme route is the part with published names behind it [1] | Write it down before the appointment starts |
| What we did not answer | No cited study here covers cannabidiol together with nicotine, and saying so is part of the standard we have kept since 2014 | This page, and the two references under it |
Frequently Asked Questions
4 questionsIs CBD broken down in the liver?
What did the 2011 laboratory work actually test?
Why do published CBD blood levels vary so much?
What should I write down before speaking to a pharmacist?
About this article
Luke Sholl has been writing about cannabinoids, CBD, and the broader benefits of nature since 2011. His background includes first-hand cannabis cultivation experience spanning the full seed-to-harvest lifecycle across so
This wiki article was drafted with AI assistance and reviewed by Luke Sholl, CBD & wellness writer. Editorial oversight by Joshua Askew.
Medical disclaimer. This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before use of any substance.
Last reviewed 27 серпня 2026 р.
References (2)
- [1]Jiang, R. et al. (2011). Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. DOI: https://doi.org/10.1016/j.lfs.2011.05.018
- [2]Millar, S.A. et al. (2018). A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. DOI: https://doi.org/10.3389/fphar.2018.01365
Related Articles
Can You Be Allergic to CBD? Two Papers, One Protein
Two published papers characterise a cannabis plant protein called Can s 3 as an allergen. Here is what they cover, what they leave open, and where the carrier oil and softgel shell fit in.
CBD and Ibuprofen: One Shared Liver Enzyme
Ibuprofen depends on a single liver enzyme, and cannabidiol has been described as an inhibitor of it. Here is what the 2011 and 2019 research documented, and where the record simply stops.
CBD That Mixes Into Water: The Actual Chemistry
The phrase exists because of one physical fact: cannabidiol and water do not mix on their own. Here is what emulsions and liposomes actually are, and where the published human measurements stop.
CBD Oil or Gummies: Where the Amount Gets Decided
The pipette leaves the counting to you; the gummy carton arrives with the number already on it. Here is what the published human data covers, and where it stops.
One Gummy, 25 mg, and What the Studies Measured
25 mg per gummy, ten in a pack, THC-free printed on the box. What happens after chewing is the part human trials are still measuring [1].
Travelling With CBD: Check Three Countries First
A country-by-country permission list for CBD is wrong by design. Here is the checking order instead: three countries per ticket, the airline's own conditions, and a clear rule for unresolved cases.
What Is A CBD Tincture? The Word And The Bottle
Tincture once described a method: extraction with alcohol. Here is how the word travelled to CBD dropper bottles, and what the ingredient list settles that the front label does not.
Combining CBD Products: Counting The Day's Milligrams
An oil in the morning and a capsule at night belong to the same daily figure, counted in milligrams. Here is how that arithmetic works, what the human pharmacokinetic literature covers, and why a topical sits in a column of its own.
Ways To Take CBD, Route By Route
A pipette bottle, a capsule and a chewable piece are not three sizes of the same thing. They sit on different routes, and published human reviews keep those routes in separate columns.
